Who owns Xeris Biopharma Holdings, Inc. (XERS)? Elite investor 13F holders
3 tracked elite investors reported holding Xeris Biopharma Holdings, Inc as of 2026-06-30, including D.E. Shaw, Renaissance Technologies LLC, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| D.E. Shaw | XERIS BIOPHARMA HOLDINGS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 61813683.00 USD | 7804758.000000 | Shares | add | Original filing |
| Voss Capital | XERIS BIOPHARMA HOLDINGS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Renaissance Technologies LLC | XERIS BIOPHARMA HOLDINGS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 533308.00 USD | 67337.000000 | Shares | reduce | Original filing |
| Gotham Asset Management | XERIS BIOPHARMA HOLDINGS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 981399.00 USD | 123914.000000 | Shares | add | Original filing |
| Tudor Investment | XERIS BIOPHARMA HOLDINGS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.